Approval · Notice of Compliance 24774 · 2020
OZANEX: Notice of Compliance 24774
Issued December 10, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24774
- Date
- December 10, 2020
- Company
- Ferrer Internacional SaBarcelona, Catalonia, Spain
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug substance manufacturing sites
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OZANEX | Not yet assigned | — |
Medicinal ingredients
- OZENOXACIN 1 PER